van den Broek M - Search Results

1

Radiotherapy promotes tumor-specific effector CD8+ T cells via dendritic cell activation.

Gupta A, Probst HC, Vuong V, Landshammer A, Muth S, Yagita H, Schwendener R, Pruschy M, Knuth A, van den Broek M. Gupta A, et al. Among authors: van den broek m. J Immunol. 2012 Jul 15;189(2):558-66. doi: 10.4049/jimmunol.1200563. Epub 2012 Jun 8. J Immunol. 2012. PMID: 22685313

2

Lactate dehydrogenase-elevating virus (LDV): lifelong coexistence of virus and LDV-specific immunity.

van den Broek MF, Spörri R, Even C, Plagemann PG, Hänseler E, Hengartner H, Zinkernagel RM. van den Broek MF, et al. J Immunol. 1997 Aug 15;159(4):1585-8. J Immunol. 1997. PMID: 9257815

3

IL-4 and IL-10 antagonize IL-12-mediated protection against acute vaccinia virus infection with a limited role of IFN-gamma and nitric oxide synthetase 2.

van Den Broek M, Bachmann MF, Köhler G, Barner M, Escher R, Zinkernagel R, Kopf M. van Den Broek M, et al. J Immunol. 2000 Jan 1;164(1):371-8. doi: 10.4049/jimmunol.164.1.371. J Immunol. 2000. PMID: 10605032 Free article.

4

The selective proteasome inhibitors lactacystin and epoxomicin can be used to either up- or down-regulate antigen presentation at nontoxic doses.

Schwarz K, de Giuli R, Schmidtke G, Kostka S, van den Broek M, Kim KB, Crews CM, Kraft R, Groettrup M. Schwarz K, et al. Among authors: van den broek m. J Immunol. 2000 Jun 15;164(12):6147-57. doi: 10.4049/jimmunol.164.12.6147. J Immunol. 2000. PMID: 10843664 Free PMC article.

5

CD8(+) T cells secreting type 2 lymphokines are defective in protection against viral infection.

Wirth S, van den Broek M, Frossard CP, Hügin AW, Leblond I, Pircher H, Hauser C. Wirth S, et al. Among authors: van den broek m. Cell Immunol. 2000 May 25;202(1):13-22. doi: 10.1006/cimm.2000.1639. Cell Immunol. 2000. PMID: 10873302

6

Cutting edge: neosynthesis is required for the presentation of a T cell epitope from a long-lived viral protein.

Khan S, de Giuli R, Schmidtke G, Bruns M, Buchmeier M, van den Broek M, Groettrup M. Khan S, et al. Among authors: van den broek m. J Immunol. 2001 Nov 1;167(9):4801-4. doi: 10.4049/jimmunol.167.9.4801. J Immunol. 2001. PMID: 11673482 Free article.

7

Cutting edge: competition for APC by CTLs of different specificities is not functionally important during induction of antiviral responses.

Probst HC, Dumrese T, van den Broek MF. Probst HC, et al. J Immunol. 2002 Jun 1;168(11):5387-91. doi: 10.4049/jimmunol.168.11.5387. J Immunol. 2002. PMID: 12023329 Free article.

8

Inducible transgenic mice reveal resting dendritic cells as potent inducers of CD8+ T cell tolerance.

Probst HC, Lagnel J, Kollias G, van den Broek M. Probst HC, et al. Among authors: van den broek m. Immunity. 2003 May;18(5):713-20. doi: 10.1016/s1074-7613(03)00120-1. Immunity. 2003. PMID: 12753747 Free article.

9

Immunodominance of an antiviral cytotoxic T cell response is shaped by the kinetics of viral protein expression.

Probst HC, Tschannen K, Gallimore A, Martinic M, Basler M, Dumrese T, Jones E, van den Broek MF. Probst HC, et al. Among authors: van den broek mf. J Immunol. 2003 Nov 15;171(10):5415-22. doi: 10.4049/jimmunol.171.10.5415. J Immunol. 2003. PMID: 14607945

10

DC infection promotes antiviral CTL priming: the 'Winkelried' strategy.

Freigang S, Probst HC, van den Broek M. Freigang S, et al. Among authors: van den broek m. Trends Immunol. 2005 Jan;26(1):13-8. doi: 10.1016/j.it.2004.11.013. Trends Immunol. 2005. PMID: 15629404 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

432 results

Search Page

Filters